|
|
|
Volumn 161, Issue 31, 1999, Pages 4400-4405
|
|
Cost of different treatment strategies to prevent hip fractures in Denmark;Okonomiske omkostninger ved forskellige interventionsregimer til forebyggelse af hoftebrud
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
ESTRADIOL;
FEMANEST;
UNCLASSIFIED DRUG;
VITAMIN D;
ADULT;
AGED;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DENMARK;
ESTROGEN THERAPY;
FEMALE;
HIGH RISK POPULATION;
HIP FRACTURE;
HORMONE SUBSTITUTION;
HUMAN;
MAJOR CLINICAL STUDY;
NURSING HOME;
POSTMENOPAUSE OSTEOPOROSIS;
VITAMIN INTAKE;
ADULT;
CALCIUM;
COSTS AND COST ANALYSIS;
DIPHOSPHONATES;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HIP FRACTURES;
HUMANS;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
PRIMARY PREVENTION;
PROTECTIVE DEVICES;
VITAMIN D;
|
|
EID: 0033517029
PISSN: 00415782
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (20)
|
